DNA methylation and expression of LINE-1 and HERV-K provirus sequences in urothelial and renal cell carcinomas

Abstract

Since DNA methylation is considered an important mechanism for silencing of retroelements in the mammalian genome, hypomethylation in human tumours may lead to their reactivation. The methylation status of LINE-1 retroposons was determined in 73 samples of urinary bladder cancers, 34 specimens of renal cell carcinoma and in the corresponding normal tissues by Southern blot analysis. LINE-1 sequences were strongly methylated in normal tissues and were significantly hypomethylated in 69 (95%) urothelial carcinomas, but in none of the renal carcinomas. Hypomethylation in bladder cancers was independent of stage and tended to increase with grade. The methylation status of HERV-K proviral DNA in normal and transformed urothelial cells paralleled that of LINE-1 sequences (r2 = 0.87). It was shown by ligation-mediated polymerase chain reaction that hypomethylation also extended to the LINE-1 promoter sequence located at the 5'-ends of full-length elements which is repressed by methylation in somatic tissues. Accordingly, full-length LINE-1 transcripts were detected by Northern blot analysis in two urothelial carcinoma cell lines. In contrast, transcripts from HERV-K proviruses were restricted to teratocarcinoma cell lines. Our data indicate that genome-wide DNA hypomethylation is an early change in urothelial carcinoma, but is absent from renal cell carcinoma. The coordinate changes of LINE-1 and HERV-K DNA methylation suggest that hypomethylation in urothelial cancer affects a variety of different retroelements to similar extents. We speculate that decreased methylation of LINE-1 retroelements, in particular, may contribute to genomic instability in specific human tumours such as urothelial carcinoma by rendering these normally repressed sequences competent for transcription and recombination.

References 37

1. 1.

   Alves G., Tatro A., Fanning T. Differential methylation of human LINE-1 retrotransposons in malignant cells. Gene. 1996;176(1-2):39-44.

   Not in our library10.1016/0378-1119(96)00205-3

2. 2.

   Baylin S. B., Herman J. G., Graff J. R., Vertino P. M., Issa J. P. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res. 1998;72:141-196.

   Not in our library

3. 3.

   Bedford M. T., van Helden P. D. Hypomethylation of DNA in pathological conditions of the human prostate. Cancer Res. 1987;47(20):5274-5276.

   Not in our library

4. 4.

   Bratthauer G. L., Fanning T. G. Active LINE-1 retrotransposons in human testicular cancer. Oncogene. 1992;7(3):507-510.

   Not in our library

5. 5.

   Chen R. Z., Pettersson U., Beard C., Jackson-Grusby L., Jaenisch R. DNA hypomethylation leads to elevated mutation rates. Nature. 1998;395(6697):89-93.

   Not in our library10.1038/25779

6. 6.

   Clifford S. C., Prowse A. H., Affara N. A., Buys C. H., Maher E. R. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis. Genes Chromosomes Cancer. 1998;22(3):200-209.

   Not in our library10.1002/(sici)1098-2264(199807)22:3<200::aid-gcc5>3.0.co;2-#

7. 7.

   Dombroski B. A., Scott A. F., Kazazian H. H. Two additional potential retrotransposons isolated from a human L1 subfamily that contains an active retrotransposable element. Proc Natl Acad Sci U S A. 1993;90(14):6513-6517.

   Not in our library10.1073/pnas.90.14.6513

8. 8.

   Feinberg A. P., Gehrke C. W., Kuo K. C., Ehrlich M. Reduced genomic 5-methylcytosine content in human colonic neoplasia. Cancer Res. 1988;48(5):1159-1161.

   Not in our library

9. 9.

   Feng Q., Moran J. V., Kazazian H. H., Boeke J. D. Human L1 retrotransposon encodes a conserved endonuclease required for retrotransposition. Cell. 1996;87(5):905-916.

   Not in our library10.1016/s0092-8674(00)81997-2

10. 10.

    Goelz S. E., Vogelstein B., Hamilton S. R., Feinberg A. P. Hypomethylation of DNA from benign and malignant human colon neoplasms. Science. 1985;228(4696):187-190.

    Not in our library10.1126/science.2579435

11. 11.

    Gonzalez-Zulueta M., Bender C. M., Yang A. S., Nguyen T., Beart R. W., Van Tornout J. M., Jones P. A. Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res. 1995;55(20):4531-4535.

    Not in our library

12. 12.

    Grimm M. O., Jürgens B., Schulz W. A., Decken K., Makri D., Schmitz-Dräger B. J. Inactivation of tumor suppressor genes and deregulation of the c-myc gene in urothelial cancer cell lines. Urol Res. 1995;23(5):293-300.

    Not in our library10.1007/bf00300017

13. 13.

    Götzinger N., Sauter M., Roemer K., Mueller-Lantzsch N. Regulation of human endogenous retrovirus-K Gag expression in teratocarcinoma cell lines and human tumours. J Gen Virol. 1996;77(Pt 12):2983-2990.

    Not in our library10.1099/0022-1317-77-12-2983

14. 14.

    Hata K., Sakaki Y. Identification of critical CpG sites for repression of L1 transcription by DNA methylation. Gene. 1997;189(2):227-234.

    Not in our library10.1016/s0378-1119(96)00856-6

15. 15.

    Herman J. G., Latif F., Weng Y., Lerman M. I., Zbar B., Liu S., Samid D., Duan D. S., Gnarra J. R., Linehan W. M. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci U S A. 1994;91(21):9700-9704.

    Not in our library10.1073/pnas.91.21.9700

16. 16.

    Herman J. G., Merlo A., Mao L., Lapidus R. G., Issa J. P., Davidson N. E., Sidransky D., Baylin S. B. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res. 1995;55(20):4525-4530.

    Not in our library

17. 17.

    Holmes S. E., Dombroski B. A., Krebs C. M., Boehm C. D., Kazazian H. H. A new retrotransposable human L1 element from the LRE2 locus on chromosome 1q produces a chimaeric insertion. Nat Genet. 1994;7(2):143-148.

    Not in our library10.1038/ng0694-143

18. 18.

    Jarrard D. F., Bova G. S., Ewing C. M., Pin S. S., Nguyen S. H., Baylin S. B., Cairns P., Sidransky D., Herman J. G., Isaacs W. B. Deletional, mutational, and methylation analyses of CDKN2 (p16/MTS1) in primary and metastatic prostate cancer. Genes Chromosomes Cancer. 1997;19(2):90-96.

    Not in our library

19. 19.

    Jürgens B., Schmitz-Dräger B. J., Schulz W. A. Hypomethylation of L1 LINE sequences prevailing in human urothelial carcinoma. Cancer Res. 1996;56(24):5698-5703.

    Not in our library

20. 20.

    Kazazian H. H., Moran J. V. The impact of L1 retrotransposons on the human genome. Nat Genet. 1998;19(1):19-24.

    Not in our library10.1038/ng0598-19

21. 21.

    Laird P. W., Jaenisch R. The role of DNA methylation in cancer genetic and epigenetics. Annu Rev Genet. 1996;30:441-464.

    Not in our library10.1146/annurev.genet.30.1.441

22. 22.

    Liu J., Nau M. M., Zucman-Rossi J., Powell J. I., Allegra C. J., Wright J. J. LINE-I element insertion at the t(11;22) translocation breakpoint of a desmoplastic small round cell tumor. Genes Chromosomes Cancer. 1997;18(3):232-239.

    Not in our library10.1002/(sici)1098-2264(199703)18:3<232::aid-gcc10>3.0.co;2-k

23. 23.

    Löwer R., Löwer J., Kurth R. The viruses in all of us: characteristics and biological significance of human endogenous retrovirus sequences. Proc Natl Acad Sci U S A. 1996;93(11):5177-5184.

    Not in our library10.1073/pnas.93.11.5177

24. 24.

    Löwer R., Löwer J., Tondera-Koch C., Kurth R. A general method for the identification of transcribed retrovirus sequences (R-U5 PCR) reveals the expression of the human endogenous retrovirus loci HERV-H and HERV-K in teratocarcinoma cells. Virology. 1993;192(2):501-511.

    Not in our library10.1006/viro.1993.1066

25. 25.

    Löwer R., Tönjes R. R., Korbmacher C., Kurth R., Löwer J. Identification of a Rev-related protein by analysis of spliced transcripts of the human endogenous retroviruses HTDV/HERV-K. J Virol. 1995;69(1):141-149.

    Not in our library10.1128/jvi.69.1.141-149.1995

26. 26.

    Merlo A., Herman J. G., Mao L., Lee D. J., Gabrielson E., Burger P. C., Baylin S. B., Sidransky D. 5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med. 1995;1(7):686-692.

    Not in our library10.1038/nm0795-686

27. 27.

    Miki Y., Nishisho I., Horii A., Miyoshi Y., Utsunomiya J., Kinzler K. W., Vogelstein B., Nakamura Y. Disruption of the APC gene by a retrotransposal insertion of L1 sequence in a colon cancer. Cancer Res. 1992;52(3):643-645.

    Not in our library

28. 28.

    Miller O. J., Schnedl W., Allen J., Erlanger B. F. 5-Methylcytosine localised in mammalian constitutive heterochromatin. Nature. 1974;251(5476):636-637.

    Not in our library10.1038/251636a0

29. 29.

    Moran J. V., Holmes S. E., Naas T. P., DeBerardinis R. J., Boeke J. D., Kazazian H. H. High frequency retrotransposition in cultured mammalian cells. Cell. 1996;87(5):917-927.

    Not in our library10.1016/s0092-8674(00)81998-4

30. 30.

    Morse B., Rotherg P. G., South V. J., Spandorfer J. M., Astrin S. M. Insertional mutagenesis of the myc locus by a LINE-1 sequence in a human breast carcinoma. Nature. 1988;333(6168):87-90.

    Not in our library10.1038/333087a0

31. 31.

    Nagarajan L., Lange B., Cannizzaro L., Finan J., Nowell P. C., Huebner K. Molecular anatomy of a 5q interstitial deletion. Blood. 1990;75(1):82-87.

    Not in our library

32. 32.

    Pomykala H. M., Bohlander S. K., Broeker P. L., Olopade O. I., Díaz M. O. Breakpoint junctions of chromosome 9p deletions in two human glioma cell lines. Mol Cell Biol. 1994;14(11):7604-7610.

    Not in our library10.1128/mcb.14.11.7604-7610.1994

33. 33.

    Santourlidis S., Florl A., Ackermann R., Wirtz H. C., Schulz W. A. High frequency of alterations in DNA methylation in adenocarcinoma of the prostate. Prostate. 1999;39(3):166-174.

    Not in our library10.1002/(sici)1097-0045(19990515)39:3<166::aid-pros4>3.0.co;2-j

34. 34.

    Schulz W. A. DNA methylation in urological malignancies (review). Int J Oncol. 1998;13(1):151-167.

    Not in our library

35. 35.

    Skowronski J., Fanning T. G., Singer M. F. Unit-length line-1 transcripts in human teratocarcinoma cells. Mol Cell Biol. 1988;8(4):1385-1397.

    Not in our library10.1128/mcb.8.4.1385-1397.1988

36. 36.

    Steigerwald S. D., Pfeifer G. P., Riggs A. D. Ligation-mediated PCR improves the sensitivity of methylation analysis by restriction enzymes and detection of specific DNA strand breaks. Nucleic Acids Res. 1990;18(6):1435-1439.

    Not in our library10.1093/nar/18.6.1435

37. 37.

    Swergold G. D. Identification, characterization, and cell specificity of a human LINE-1 promoter. Mol Cell Biol. 1990;10(12):6718-6729.

    Not in our library10.1128/mcb.10.12.6718-6729.1990

Cited by papers we hold 6

• HERV-K(HML-2), the Best Preserved Family of HERVs: Endogenization, Expression, and Implications in Health and Disease · 2013
  No notice
• Birthweight, Maternal Weight Trajectories and Global DNA Methylation of LINE-1 Repetitive Elements · 2011
  No notice
• Hypomethylation of a LINE-1 Promoter Activates an Alternate Transcript of the MET Oncogene in Bladders with Cancer · 2010
  No notice
• Epigenomic Consequences of Immortalized Plant Cell Suspension Culture · 2008
  No notice
• LINE-1 Hypomethylation in Cancer Is Highly Variable and Inversely Correlated with Microsatellite Instability · 2007
  No notice
• Coordinate hypermethylation at specific genes in prostate carcinoma precedes LINE-1 hypomethylation · 2004
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.